These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 242209)
1. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Bühler FR; Burkart F; Lütold BE; Küng M; Marbet G; Pfisterer M Am J Cardiol; 1975 Oct; 36(5):653-69. PubMed ID: 242209 [TBL] [Abstract][Full Text] [Related]
2. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension. Kralberg BE; Tolagen K Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504 [TBL] [Abstract][Full Text] [Related]
3. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program. Bühler FR; Lütold BE Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485 [TBL] [Abstract][Full Text] [Related]
4. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499 [TBL] [Abstract][Full Text] [Related]
6. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)]. Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663 [TBL] [Abstract][Full Text] [Related]
7. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents. Stokes GS; Graham RM; Weber MA Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247 [TBL] [Abstract][Full Text] [Related]
8. A beta-blocker-based antihypertensive drug program guided by age and renin. Bühler FR; Lütold BE Aust N Z J Med; 1976 Aug; 6(3 Suppl):29-36. PubMed ID: 14622 [TBL] [Abstract][Full Text] [Related]
9. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension. Tsukiyama H; Otsuka K; Horii M; Yoshii Y; Hatori Y; Nakamura Y; Nemoto E; Yamato T; Sakai T; Yamamoto Y Jpn Circ J; 1983 Mar; 47(3):313-22. PubMed ID: 6132016 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. Antonaccio MJ; High J; DeForrest JM; Sybertz E J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of propranolol in hypertension. Frohlich ED South Med J; 1977 Jan; 70(1):95-9. PubMed ID: 14402 [TBL] [Abstract][Full Text] [Related]
12. The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension. Salvetti A; Sassano P; Poli L; Arzilli F; Pedrinelli R Eur J Clin Invest; 1977 Oct; 7(5):331-6. PubMed ID: 411663 [TBL] [Abstract][Full Text] [Related]
13. Once daily dosage beta-blockade: antihypertensive efficacy of slow release oxprenolol as related to renin and age. Bühler FR; Lütold BE; Küng M; Koller FJ Aust N Z J Med; 1976 Aug; 6(3 Suppl):37-43. PubMed ID: 1071402 [TBL] [Abstract][Full Text] [Related]
14. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit. Weber MA; Oates HF; Stokes GS Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880 [TBL] [Abstract][Full Text] [Related]
15. Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension. Bravo EL; Tarazi RC; Dustan HP; Lewis JW Circ Res; 1975 Jun; 36(6 Suppl 1):241-7. PubMed ID: 236841 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. Wilcox RG; Hampton JR Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103 [TBL] [Abstract][Full Text] [Related]
17. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment. Davies R; Payne NN; Slater JD Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963 [TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. Bravo EL; Tarazi RC; Dustan HP N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005 [TBL] [Abstract][Full Text] [Related]
19. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ; Schalekamp MA Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [TBL] [Abstract][Full Text] [Related]
20. Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension. Prichard BN Br J Clin Pharmacol; 1982 Jan; 13(1):51-60. PubMed ID: 6121573 [No Abstract] [Full Text] [Related] [Next] [New Search]